Avid Bioservices News and Activities

Avid Bioservices is owned by GHO Capital. GHO Capital has a direct presence in 2 countries.

GHO Capital has 5 subsidiaries including Avid Bioservices, DNA Diagnostics Center and Genesis Research.

They are in:

• Biotechnology67%
• Fund17%
• Other17%

Acquisition, funding and merger involving GHO Capital.

• GHO Capital has acquired Avid Bioservices (posted on November 7 2024).

View the org chart displaying its 21 main executives

Most searched biographies at Avid Bioservices

• Kenneth Bilenberg, Group President and Chief Executive Officer
• Richard McAvoy, Chief Financial Officer
• Kerri McCullough, Chief Commercial Officer

Popular executive movements at Avid Bioservices

• Richard McAvoy, who was Chief Business Officer, is promoted to Chief Financial Officer  (posted on June 22 2026).
• Maria Ebro Andreasen has joined the company as Chief People Officer  (posted on May 19 2026).
• Greg Terry, who was Interim Chief Commercial Officer, is promoted to Vice President, Strategic Partnerships and Key Accounts  (posted on May 12 2026).

Click here to view some more movements at Avid Bioservices

Create your alert
to follow the executive moves at Avid Bioservices.

GHO Capital has 2,413 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Ollin Biosciences has just announced a $330 Million fundraising (posted on June 24 2026).
• RQ Biotechnology has just announced a $86 Million fundraising (posted on June 24 2026).
• Boundless Bio has filed its IPO. Its stock ticker will be AATD. (posted on June 23 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by Avid Bioservices

• Avid Bioservices Appoints Maria Ebro Andreasen as Chief People Officer to Fuel Continued Growth and Talent Strategy - Avid Bioservices
• Avid Bioservices Appoints Kerri McCullough Wood as Chief Commercial Officer - Avid Bioservices
• Avid Bioservices Announces Grand Opening of New Early Phase Center of Excellence in Costa Mesa, California  - Avid Bioservices
• Avid Bioservices Appoints Rich McAvoy as Chief Business Officer - Avid Bioservices
• Avid Bioservices appoints Dave Stewart as Chief Technology and Transformation Officer - Avid Bioservices
• Avid Bioservices appoints Dave Stewart as Chief Technology and Transformation Officer - Avid Bioservices
• Avid Bioservices Welcomes Kenneth Bilenberg as New CEO - Avid Bioservices
• CHO Plus Enters into Project Agreement with BARDA’s BioMaP Consortium to Develop High Productivity Cell Lines for Filovirus Monoclonal Antibody Production - Avid Bioservices
• Avid Stockholders Approve Transaction with GHO and Ampersand – Avid Bioservices
• Avid Bioservices, Inc. Provides Notice of Fundamental Change and Make-Whole Fundamental Change to Holders of its Convertible Notes in Connection with Completed Merger – Avid Bioservices
• View more press releases Close

Social media about Avid Bioservices

• Avid Bioservices on Wikipedia, Google News & Yahoo Finance
• Avid Bioservices on LinkedIn, X (Twitter) & YouTube